Works matching IS 11001704 AND DT 2018 AND VI 57 AND IP 9

Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial.

Published in:

Acta Oncologica. Supplement, 2018, v. 57, n. 9, p. 1159, doi. 10.1080/0284186X.2018.1464664

By:

• Brøndum, Line;
• Alsner, Jan;
• Sørensen, Brita Singers;
• Maare, Christian;
• Johansen, Jørgen;
• Primdahl, Hanne;
• Evensen, Jan Folkvard;
• Kristensen, Claus Andrup;
• Andersen, Lisbeth Juhler;
• Overgaard, Jens;
• Eriksen, Jesper Grau

Publication type:

Article